Regeneron Pharmaceuticals Inc REGN gained 8% to $598.51 after the company reported upbeat results for the second quarter and raised its FY15 EYLEA sales forecast. Share volume was 691,000, compared to an all-day average of 727,000
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
